Lucid Diagnostics Correlations
LUCD Stock | USD 1.12 0.02 1.75% |
The current 90-days correlation between Lucid Diagnostics and PAVmed Inc is 0.19 (i.e., Average diversification). The correlation of Lucid Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Lucid Diagnostics Correlation With Market
Good diversification
The correlation between Lucid Diagnostics and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lucid Diagnostics and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Lucid Stock
Moving against Lucid Stock
0.61 | DOCS | Doximity | PairCorr |
0.5 | GH | Guardant Health | PairCorr |
0.43 | VNRX | Volitionrx | PairCorr |
0.36 | VERO | Venus Concept | PairCorr |
0.34 | DH | Definitive Healthcare | PairCorr |
0.51 | VVOS | Vivos Therapeutics | PairCorr |
0.51 | FIGS | Figs Inc | PairCorr |
0.47 | CVS | CVS Health Corp | PairCorr |
0.42 | MDAI | Spectral AI | PairCorr |
0.4 | MODV | ModivCare | PairCorr |
0.32 | MGRM | Monogram Orthopaedics Trending | PairCorr |
0.31 | NDRA | ENDRA Life Sciences | PairCorr |
Related Correlations Analysis
0.11 | -0.03 | 0.01 | 0.59 | 0.0 | -0.06 | PAVM | ||
0.11 | -0.64 | 0.19 | 0.65 | 0.0 | -0.52 | NPCE | ||
-0.03 | -0.64 | 0.02 | -0.36 | 0.0 | 0.56 | HYPR | ||
0.01 | 0.19 | 0.02 | -0.04 | 0.0 | 0.21 | KIDS | ||
0.59 | 0.65 | -0.36 | -0.04 | 0.0 | -0.23 | HCWB | ||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | UTRS | ||
-0.06 | -0.52 | 0.56 | 0.21 | -0.23 | 0.0 | CGTX | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Lucid Stock performing well and Lucid Diagnostics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lucid Diagnostics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
PAVM | 3.12 | (0.36) | 0.00 | (0.15) | 0.00 | 6.06 | 27.59 | |||
NPCE | 3.11 | (0.11) | 0.00 | (20.60) | 0.00 | 5.22 | 48.86 | |||
HYPR | 5.16 | 0.47 | 0.11 | 0.33 | 4.89 | 21.13 | 54.61 | |||
KIDS | 1.83 | (0.10) | (0.02) | 0.06 | 2.24 | 4.06 | 11.10 | |||
HCWB | 6.20 | (0.13) | 0.00 | 0.22 | 0.00 | 9.86 | 105.24 | |||
UTRS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
CGTX | 7.15 | 1.18 | 0.16 | 0.70 | 6.58 | 20.59 | 60.03 |
Lucid Diagnostics Corporate Management
Lishan MD | Chairman CEO | Profile | |
Joseph MD | Strategic Cofounder | Profile | |
Deepika Lakhani | Chief Officer | Profile | |
Michael Gordon | General Secretary | Profile | |
Michael Parks | Vice Relations | Profile | |
Adrian Miller | VP Relations | Profile | |
Amitabh MD | Strategic Cofounder | Profile |